Interchange Capital Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$207K Buy
+935
New +$204K 0.03% 425
2025
Q4
– Sell
-849
Closed -$232K – 450
2025
Q3
$232K Buy
+849
New +$232K 0.05% 319
2021
Q1
– Sell
-53
Closed -$11K – 915
2020
Q4
$11K Buy
+53
New +$10.6K 0.01% 775

Other funds holding RMD

Interchange Capital Partners's RMD Position: Q3 2026 in Review

Interchange Capital Partners opened a new position in ResMed (RMD) in Q3 2026: 935 shares worth $207K. The stake represents 0.03% of the portfolio and ranks #425 among its holdings. This is a return to the name: Interchange Capital Partners previously reported a position in RMD as recently as Q3 2025.

Interchange Capital Partners first reported a position in RMD in Q4 2020 and has held it in 3 quarters since. The position peaked at $232K in Q3 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Interchange Capital Partners held 935 shares of ResMed worth $207K as of Q3 2026.
  • ResMed was a new Interchange Capital Partners position in Q3 2026.
  • ResMed made up 0.03% of Interchange Capital Partners's portfolio in Q3 2026, its #425 holding.
  • Interchange Capital Partners first reported a position in ResMed in Q4 2020 and has held it in 3 quarters since.
  • Interchange Capital Partners's ResMed position peaked at $232K in Q3 2025.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Interchange Capital Partners's 13F filing for Q3 2026, filed 28 Oct 2026.